JP2005504121A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504121A5 JP2005504121A5 JP2003532442A JP2003532442A JP2005504121A5 JP 2005504121 A5 JP2005504121 A5 JP 2005504121A5 JP 2003532442 A JP2003532442 A JP 2003532442A JP 2003532442 A JP2003532442 A JP 2003532442A JP 2005504121 A5 JP2005504121 A5 JP 2005504121A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- group
- propionylamino
- methyl
- iodide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 C 1 -C 4 alkyl Chemical group 0.000 claims 39
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 11
- 229910052757 nitrogen Inorganic materials 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims 3
- 229910052717 sulfur Chemical group 0.000 claims 3
- 125000004434 sulfur atom Chemical group 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 2
- 239000000460 chlorine Chemical group 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 239000011737 fluorine Chemical group 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 150000002431 hydrogen Chemical group 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 125000001639 phenylmethylene group Chemical group [H]C(=*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- HBPSMMXRESDUSG-UHFFFAOYSA-N piperidine;hydroiodide Chemical compound I.C1CCNCC1 HBPSMMXRESDUSG-UHFFFAOYSA-N 0.000 claims 2
- DTYCLCKCZXMPME-UHFFFAOYSA-N propanamide hydroiodide Chemical compound CCC(N)=O.I DTYCLCKCZXMPME-UHFFFAOYSA-N 0.000 claims 2
- 229940080818 propionamide Drugs 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- YEVPPETYWLJSBU-VEIFNGETSA-N (2r)-2-(3-benzoylphenyl)-n-[3-(1-methylpiperidin-1-ium-1-yl)propyl]propanamide;iodide Chemical compound [I-].O=C([C@H](C)C=1C=C(C=CC=1)C(=O)C=1C=CC=CC=1)NCCC[N+]1(C)CCCCC1 YEVPPETYWLJSBU-VEIFNGETSA-N 0.000 claims 1
- RJMIEHBSYVWVIN-LLVKDONJSA-N (2r)-2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]propanoic acid Chemical compound C1=CC([C@H](C(O)=O)C)=CC=C1N1C(=O)C2=CC=CC=C2C1 RJMIEHBSYVWVIN-LLVKDONJSA-N 0.000 claims 1
- CQECGMFUMPDYPA-FSRHSHDFSA-N (2r)-n-[3-(1-methylpiperidin-1-ium-1-yl)propyl]-2-[4-(2-methylpropyl)phenyl]propanamide;iodide Chemical compound [I-].C1=CC(CC(C)C)=CC=C1[C@@H](C)C(=O)NCCC[N+]1(C)CCCCC1 CQECGMFUMPDYPA-FSRHSHDFSA-N 0.000 claims 1
- IUISTMZCVYVSRL-GMUIIQOCSA-N (2r)-n-[3-(4-methylmorpholin-4-ium-4-yl)propyl]-2-[4-(2-methylpropyl)phenyl]propanamide;iodide Chemical compound [I-].C1=CC(CC(C)C)=CC=C1[C@@H](C)C(=O)NCCC[N+]1(C)CCOCC1 IUISTMZCVYVSRL-GMUIIQOCSA-N 0.000 claims 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 claims 1
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 claims 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims 1
- 125000006730 (C2-C5) alkynyl group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- MNKFLCYZIHOFRQ-UHFFFAOYSA-N 1-cyclohexyl-n,n-dimethylmethanamine Chemical compound CN(C)CC1CCCCC1 MNKFLCYZIHOFRQ-UHFFFAOYSA-N 0.000 claims 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- IQBGCARFBIPTJJ-FSRHSHDFSA-N 3-[[(2r)-2-(3-benzoylphenyl)propanoyl]amino]propyl-dimethyl-propan-2-ylazanium;iodide Chemical compound [I-].CC(C)[N+](C)(C)CCCNC(=O)[C@H](C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 IQBGCARFBIPTJJ-FSRHSHDFSA-N 0.000 claims 1
- SNTRLALYUNHMAK-UNTBIKODSA-N 3-[[(2r)-2-(3-benzoylphenyl)propanoyl]amino]propyl-trimethylazanium;iodide Chemical compound [I-].C[N+](C)(C)CCCNC(=O)[C@H](C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 SNTRLALYUNHMAK-UNTBIKODSA-N 0.000 claims 1
- DCHZLHDQGXJAAP-XFULWGLBSA-N 3-[[(2r)-2-[2-(2,6-dichloroanilino)phenyl]propanoyl]amino]propyl-trimethylazanium;methanesulfonate Chemical compound CS([O-])(=O)=O.C[N+](C)(C)CCCNC(=O)[C@H](C)C1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCHZLHDQGXJAAP-XFULWGLBSA-N 0.000 claims 1
- ZVBRKKUDZPQBRZ-UNTBIKODSA-N 3-[[(2r)-2-[4-(cyclopentylmethyl)phenyl]propanoyl]amino]propyl-trimethylazanium;iodide Chemical compound [I-].C1=CC([C@H](C(=O)NCCC[N+](C)(C)C)C)=CC=C1CC1CCCC1 ZVBRKKUDZPQBRZ-UNTBIKODSA-N 0.000 claims 1
- ZHBMGKRWRNEMOQ-UHFFFAOYSA-N 4-methylbenzenesulfonate;piperidin-1-ium Chemical compound C1CCNCC1.CC1=CC=C(S(O)(=O)=O)C=C1 ZHBMGKRWRNEMOQ-UHFFFAOYSA-N 0.000 claims 1
- KDTVWEHAAISPNW-UHFFFAOYSA-N 4-methylthiomorpholine Chemical compound CN1CCSCC1 KDTVWEHAAISPNW-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- LWANHKYKSHZOAS-UHFFFAOYSA-N 5-(1-methylpiperidin-1-ium-1-yl)-2-[2-[4-(2-methylpropyl)phenyl]propanoylamino]pentanoic acid;iodide Chemical compound [I-].C1=CC(CC(C)C)=CC=C1C(C)C(=O)NC(C(O)=O)CCC[N+]1(C)CCCCC1 LWANHKYKSHZOAS-UHFFFAOYSA-N 0.000 claims 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- GHCVDAJWXCXGEN-UHFFFAOYSA-N CN(C)NC1CCCC1 Chemical compound CN(C)NC1CCCC1 GHCVDAJWXCXGEN-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 claims 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 claims 1
- 206010034277 Pemphigoid Diseases 0.000 claims 1
- 241000721454 Pemphigus Species 0.000 claims 1
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- MUXFZBHBYYYLTH-UHFFFAOYSA-N Zaltoprofen Chemical compound O=C1CC2=CC(C(C(O)=O)C)=CC=C2SC2=CC=CC=C21 MUXFZBHBYYYLTH-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 229960005430 benoxaprofen Drugs 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 125000001589 carboacyl group Chemical group 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 125000005518 carboxamido group Chemical group 0.000 claims 1
- 229960003184 carprofen Drugs 0.000 claims 1
- IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- ITKDGNDHTCDLFN-ZMBIFBSDSA-N cyclohexylmethyl-dimethyl-[3-[[(2r)-2-[4-(2-methylpropyl)phenyl]propanoyl]amino]propyl]azanium;iodide Chemical compound [I-].C1=CC(CC(C)C)=CC=C1[C@@H](C)C(=O)NCCC[N+](C)(C)CC1CCCCC1 ITKDGNDHTCDLFN-ZMBIFBSDSA-N 0.000 claims 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-O dimethylaminium Chemical compound C[NH2+]C ROSDSFDQCJNGOL-UHFFFAOYSA-O 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- XMXGJNCYISPPDR-UNTBIKODSA-N ethyl-dimethyl-[3-[[(2r)-2-[4-(2-methylpropyl)phenyl]propanoyl]amino]propyl]azanium;iodide Chemical compound [I-].CC[N+](C)(C)CCCNC(=O)[C@H](C)C1=CC=C(CC(C)C)C=C1 XMXGJNCYISPPDR-UNTBIKODSA-N 0.000 claims 1
- 229960001395 fenbufen Drugs 0.000 claims 1
- ZPAKPRAICRBAOD-UHFFFAOYSA-N fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 claims 1
- 229960001419 fenoprofen Drugs 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 229960002390 flurbiprofen Drugs 0.000 claims 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- 229960004187 indoprofen Drugs 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 1
- 229960000991 ketoprofen Drugs 0.000 claims 1
- 229960002373 loxoprofen Drugs 0.000 claims 1
- YMBXTVYHTMGZDW-UHFFFAOYSA-N loxoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1CC1C(=O)CCC1 YMBXTVYHTMGZDW-UHFFFAOYSA-N 0.000 claims 1
- YZHIFLREQAZKAB-UNTBIKODSA-N methanesulfonate;(2r)-n-[3-(4-methylthiomorpholin-4-ium-4-yl)propyl]-2-(3-propan-2-ylphenyl)propanamide Chemical compound CS([O-])(=O)=O.CC(C)C1=CC=CC([C@@H](C)C(=O)NCCC[N+]2(C)CCSCC2)=C1 YZHIFLREQAZKAB-UNTBIKODSA-N 0.000 claims 1
- CBATUQSECWXTQY-UHFFFAOYSA-N methanesulfonic acid propanamide Chemical compound CCC(N)=O.CS(O)(=O)=O CBATUQSECWXTQY-UHFFFAOYSA-N 0.000 claims 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 claims 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 230000028550 monocyte chemotaxis Effects 0.000 claims 1
- GNVRJGIVDSQCOP-UHFFFAOYSA-N n-ethyl-n-methylethanamine Chemical compound CCN(C)CC GNVRJGIVDSQCOP-UHFFFAOYSA-N 0.000 claims 1
- ISRXMEYARGEVIU-UHFFFAOYSA-N n-methyl-n-propan-2-ylpropan-2-amine Chemical compound CC(C)N(C)C(C)C ISRXMEYARGEVIU-UHFFFAOYSA-N 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- 210000000440 neutrophil Anatomy 0.000 claims 1
- 230000011242 neutrophil chemotaxis Effects 0.000 claims 1
- 230000007170 pathology Effects 0.000 claims 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000003367 polycyclic group Chemical group 0.000 claims 1
- 229960003101 pranoprofen Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 claims 1
- UHRTUOQJNRWDMI-PKLMIRHRSA-N trimethyl-[3-[[(2r)-2-[4-(2-methylpropyl)phenyl]propanoyl]amino]propyl]azanium;iodide Chemical compound [I-].CC(C)CC1=CC=C([C@@H](C)C(=O)NCCC[N+](C)(C)C)C=C1 UHRTUOQJNRWDMI-PKLMIRHRSA-N 0.000 claims 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims 1
- 229950004227 zaltoprofen Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI002025A ITMI20012025A1 (it) | 2001-09-28 | 2001-09-28 | Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono |
| PCT/EP2002/010746 WO2003029187A1 (en) | 2001-09-28 | 2002-09-25 | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005504121A JP2005504121A (ja) | 2005-02-10 |
| JP2005504121A5 true JP2005504121A5 (enExample) | 2005-12-22 |
| JP4405801B2 JP4405801B2 (ja) | 2010-01-27 |
Family
ID=11448449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003532442A Expired - Fee Related JP4405801B2 (ja) | 2001-09-28 | 2002-09-25 | Ｒ−２−アリール−プロピオン酸のオメガ−アミノアルキルアミドの４級アンモニウム塩及びそれらを含有する医薬組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7026510B2 (enExample) |
| EP (1) | EP1430020B1 (enExample) |
| JP (1) | JP4405801B2 (enExample) |
| AU (1) | AU2002338784B2 (enExample) |
| CA (1) | CA2458035C (enExample) |
| CY (1) | CY1117657T1 (enExample) |
| DK (1) | DK1430020T3 (enExample) |
| ES (1) | ES2573531T3 (enExample) |
| HU (1) | HU230541B1 (enExample) |
| IT (1) | ITMI20012025A1 (enExample) |
| NO (1) | NO328879B1 (enExample) |
| PL (1) | PL214275B1 (enExample) |
| PT (1) | PT1430020E (enExample) |
| RU (1) | RU2291857C2 (enExample) |
| SI (1) | SI1430020T1 (enExample) |
| WO (1) | WO2003029187A1 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1457485A1 (en) * | 2003-03-14 | 2004-09-15 | Dompé S.P.A. | Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| WO2004091597A2 (en) * | 2003-04-15 | 2004-10-28 | Pharmacia & Upjohn Company Llc | Method of treating irritable bowel syndrome (ibs) |
| PT1776336E (pt) * | 2004-03-23 | 2009-12-18 | Dompe Spa | Derivados de ácido 2-fenilpropiónico e composições farmacêuticas que os contêm |
| NZ555502A (en) * | 2004-12-15 | 2010-12-24 | Dompe Pha R Ma Spa Res & Mfg | 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| EP1739078A1 (de) | 2005-05-30 | 2007-01-03 | Jerini AG | C5a-Rezeptor-Antagonisten |
| US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
| US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
| CA2657636C (en) * | 2006-07-18 | 2021-11-09 | Techfields Biochem Co. Ltd | Positively charged water soluble prodrugs of ibuprofen with very fast skin penetration rate |
| CN104610077B (zh) * | 2006-07-27 | 2020-04-14 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 |
| CN108250090B (zh) * | 2006-07-27 | 2021-08-20 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 |
| CN103772259B (zh) * | 2006-08-08 | 2016-08-31 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药 |
| CN103772258B (zh) * | 2006-08-08 | 2016-09-28 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药 |
| PL2049482T3 (pl) * | 2006-08-08 | 2016-04-29 | Techfields Biochem Co Ltd | Dodatnio naładowane rozpuszczalne w wodzie proleki kwasów arylo- i heteroarylooctowych o bardzo dużej szybkości przenikania przez skórę |
| CN101506161B (zh) * | 2006-08-15 | 2013-11-13 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基和杂芳基丙酸类前药 |
| AU2013206218B2 (en) * | 2006-08-15 | 2016-06-30 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
| WO2008149181A1 (en) | 2007-06-04 | 2008-12-11 | Techfields Inc | Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| DE602008005488D1 (de) * | 2007-10-18 | 2011-04-21 | Dompe Spa | (r)-4-(heteroaryl)phenylethylderivate und pharmazeutische zusammensetzungen damit |
| RU2630577C2 (ru) | 2008-12-04 | 2017-09-11 | Чунси ЮЙ | Композиции интенсивного проникновения и их применение |
| SMT202200074T1 (it) | 2008-12-22 | 2022-03-21 | Chemocentryx Inc | Antagonisti di c5ar |
| EP2995303A1 (en) | 2009-07-10 | 2016-03-16 | President and Fellows of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
| KR20130073822A (ko) * | 2011-12-23 | 2013-07-03 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 이온 액체, 비수 전해질 및 축전 장치 |
| JP5940036B2 (ja) * | 2013-10-08 | 2016-06-29 | テックフィールズ バイオケム カンパニー リミテッド | 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ |
| JP6836502B2 (ja) * | 2014-05-30 | 2021-03-03 | スプハエラ ファーマ ピーヴィーティー リミテッド | 抗結核薬としての新規な化合物 |
| EP3682879B1 (en) | 2014-09-29 | 2022-08-03 | ChemoCentryx, Inc. | Processes and intermediates in the preparation of c5ar antagonists |
| WO2017024037A1 (en) * | 2015-08-03 | 2017-02-09 | President And Fellows Of Harvard College | Charged ion channel blockers and methods for use |
| MX2022006069A (es) | 2016-01-14 | 2023-01-12 | Chemocentryx Inc | Metodo para tratar glomerulopatia c3. |
| WO2017176620A2 (en) | 2016-04-04 | 2017-10-12 | Chemocentryx, Inc. | SOLUBLE C5aR ANTAGONISTS |
| KR102586710B1 (ko) | 2017-05-31 | 2023-10-10 | 케모센트릭스, 인크. | C5a 억제제로서의 5-5 융합 고리 |
| NZ759297A (en) | 2017-05-31 | 2026-03-27 | Chemocentryx Inc | 6-5 fused rings as c5a inhibitors |
| CA3077395A1 (en) | 2017-10-30 | 2019-05-09 | Chemocentryx, Inc. | Deuterated compounds as immunomodulators |
| CN111788184B (zh) | 2017-12-22 | 2023-12-22 | 凯莫森特里克斯股份有限公司 | 用作C5aR抑制剂的二芳基取代的5,5-稠合环化合物 |
| WO2019126424A1 (en) | 2017-12-22 | 2019-06-27 | Chemocentryx, Inc. | DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS |
| ES2993034T3 (en) | 2018-04-02 | 2024-12-20 | Chemocentryx Inc | Prodrugs of fused-bicyclic c5ar antagonists |
| US20200231545A1 (en) * | 2019-01-03 | 2020-07-23 | President And Fellows Of Harvard College | Charged ion channel blockers and methods for use thereof |
| EP3937945A4 (en) | 2019-03-11 | 2023-01-04 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| MA55307A (fr) | 2019-03-11 | 2022-01-19 | Nocion Therapeutics Inc | Bloqueurs de canaux ioniques chargés et procédés d'utilisation |
| BR112021017809A2 (pt) | 2019-03-11 | 2021-11-23 | Nocion Therapeutics Inc | Bloqueadores de canais iônicos substituídos por éster e métodos para uso |
| WO2021091585A1 (en) | 2019-11-06 | 2021-05-14 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US12162851B2 (en) | 2020-03-11 | 2024-12-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| JP7708777B2 (ja) | 2020-03-11 | 2025-07-15 | ノシオン セラピューティクス，インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1593024A (enExample) | 1968-09-18 | 1970-05-25 | ||
| IT1090782B (it) * | 1977-11-30 | 1985-06-26 | Menarini Sas | 2 4 bifenilil 2 dietilamino alchil propionamide suoi sali e procedimenti di fabbricazione relativi |
| RU2105554C1 (ru) * | 1997-06-24 | 1998-02-27 | Всероссийский научный центр по безопасности биологически активных веществ | N-(2,4,6-триметилфенилкарбамоилметил)-n-аллилморфолиний бромид, проявляющий противоишемическое и антиаритмическое действие при ишемической болезни сердца и способ его получения |
| IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
| US20020160988A1 (en) * | 2001-02-20 | 2002-10-31 | Israel Institute For Biological Research | Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| ITMI20010395A1 (it) * | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
-
2001
- 2001-09-28 IT IT2001MI002025A patent/ITMI20012025A1/it unknown
-
2002
- 2002-09-25 ES ES02777207.8T patent/ES2573531T3/es not_active Expired - Lifetime
- 2002-09-25 SI SI200231073A patent/SI1430020T1/sl unknown
- 2002-09-25 WO PCT/EP2002/010746 patent/WO2003029187A1/en not_active Ceased
- 2002-09-25 JP JP2003532442A patent/JP4405801B2/ja not_active Expired - Fee Related
- 2002-09-25 US US10/487,679 patent/US7026510B2/en not_active Expired - Lifetime
- 2002-09-25 PT PT02777207T patent/PT1430020E/pt unknown
- 2002-09-25 PL PL369511A patent/PL214275B1/pl unknown
- 2002-09-25 AU AU2002338784A patent/AU2002338784B2/en not_active Ceased
- 2002-09-25 DK DK02777207.8T patent/DK1430020T3/en active
- 2002-09-25 HU HU0401763A patent/HU230541B1/hu unknown
- 2002-09-25 EP EP02777207.8A patent/EP1430020B1/en not_active Expired - Lifetime
- 2002-09-25 CA CA2458035A patent/CA2458035C/en not_active Expired - Fee Related
- 2002-09-25 RU RU2004113099/04A patent/RU2291857C2/ru not_active IP Right Cessation
-
2004
- 2004-04-20 NO NO20041609A patent/NO328879B1/no not_active IP Right Cessation
-
2016
- 2016-05-27 CY CY20161100463T patent/CY1117657T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2458035A1 (en) | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | |
| RU2003128992A (ru) | Омега-аминоалкиламиды r-2-арилпропионовых кислот в качестве ингибиторов хемотаксиса полиморфноядерных и одноядерных клеток | |
| JP4194761B2 (ja) | Ｎ−（２−アリール−プロピオニル）−スルホンアミド類及びそれらを含む医薬製剤 | |
| ES2673160T5 (es) | Moduladores selectivos del receptor de la esfingosina 1 fosfato y métodos de síntesis quiral | |
| AU2002338784A1 (en) | Quaternary ammonium salts of omega-aminoalkylamides of R-2-aryl-propionic acids and pharmaceutical compositions containing them | |
| JP4220897B2 (ja) | ピペラジン化合物 | |
| HU227280B1 (en) | Nitro compounds and their compositions having anti-inflammatory, analgesic and antithrombotic acitivities | |
| RU2003120798A (ru) | Новые производные n-(фенилсульфонил) глицина и их применение в терапии | |
| JP2009533351A5 (enExample) | ||
| RU2001113733A (ru) | N-(2-арилпропионил) сульфонамиды и содержащие их фармацевтические препараты | |
| JP2009521467A5 (enExample) | ||
| JPWO2002014265A1 (ja) | 新規３置換尿素誘導体およびその医薬としての用途 | |
| JP5423905B2 (ja) | 新規化合物及びその医薬用途 | |
| PT1606248E (pt) | Ácidos sulfónicos, os seus derivados e composições farmacêuticas que os contêm | |
| EP1458378B1 (en) | Amino acid derivatives useful for the treatment of alzheimer's disease | |
| JP2006520367A5 (enExample) | ||
| JP2007532582A5 (enExample) | ||
| JP2006512321A5 (enExample) | ||
| WO2002100410A1 (en) | Methods of treating alzheimer's disease | |
| KR20200116065A (ko) | 항암활성을 갖는 신규한 화합물 및 이의 제조방법 | |
| JP5921555B2 (ja) | 新規メチルシクロヘキサン誘導体およびその使用 | |
| JPH08291059A (ja) | ２，３−ジアミノプロピオン酸誘導体を含有する経口用治療剤 | |
| ZA200206486B (en) | Substituted 8, 8a-dihydro-3aH-indeno[1,2-d]thiazoles, a method for their production and their use as medicaments. |